On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like Teva Backpedals on 6,000 Job Cuts, Says Figure is Too High March 22, 2017 Xeris Raises $55M for Glucagon Rescue Pen March 8, 2018 Novartis AG Rejects Proposition to Create More U.S Jobs June 20, 2017
